Since ODYSSEY Outcomes demonstrated a reduction in adverse CV outcomes—as well as a decrease in associated, all-cause mortality—in post-ACS patients, what is your view on treating to push LDL-C levels to even lower levels than the 70 mg/dL threshold?

Since ODYSSEY Outcomes demonstrated a reduction in adverse CV outcomes—as well as a decrease in associated, all-cause mortality—in post-ACS patients, what is your view on treating to push LDL-C levels to even lower levels than the 70 mg/dL threshold?

CLICK HERE FOR CME CREDIT

Since ODYSSEY Outcomes demonstrated a reduction in adverse CV outcomes—as well as a decrease in associated, all-cause mortality—in post-ACS patients, what is your view on treating to push LDL-C levels to even lower levels than the 70 mg/dL threshold?

Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | The Medical Cardiology, Interventional Cardiology, Lipid Medicine, Atherosclerosis and Diabetes Specialist's Perspective

Presenter

R. Scott Wright, MD

R. Scott Wright, MD

Professor of Medicine Department of Cardiovascular Medicine Cardiovascular Division Mayo Clinic